UNIVERSITATSMEDIZIN GREIFSWALD KORPERSCHAFT DES OFFENTLICHEN RECHTS

Their core work

Universitätsmedizin Greifswald is a German university medical center that combines clinical medicine with computational neuroscience, epidemiology, and bioinformatics research. They are a long-standing contributor to the Human Brain Project, providing expertise in brain simulation, neuroinformatics, and high-performance computing for neuroscience applications. Beyond brain research, they coordinate population health studies — including iodine deficiency prevention across Europe and citizen-science-driven cohort research — and contribute systems biology expertise to industrial biotechnology projects involving microbial expression systems and bioprocessing.

What they specialise in

How they've shifted over time

In the early period (2015-2018), UMG's work split between initial Human Brain Project contributions focused on brain reconstruction and transcriptomics, a coordinated public health project on thyroid disease prevention, and exploratory biotechnology work on lipid rafts and microbial chassis. From 2019 onward, their neuroscience commitment deepened significantly — with HBP SGA3 and ICEI emphasizing research infrastructure, EBRAINS, and neuromorphic computing — while new threads emerged in FAIR data principles, cardiovascular data platforms, virus bioinformatics, and citizen-engaged cohort research. The overall trajectory shows a medical center evolving from clinical epidemiology toward large-scale data infrastructure and computational biology.

UMG is moving toward research data infrastructure and citizen-engaged health studies, making them a strong partner for projects needing FAIR data expertise or population-level health analytics.

How they like to work

UMG operates overwhelmingly as a participant (10 of 12 projects), joining large flagship consortia like the Human Brain Project rather than leading them. Their two coordinated projects are mid-sized health studies (EUthyroid, JoinUs4Health), suggesting they take the lead on epidemiological themes close to their clinical mission. With 254 unique partners across 32 countries, they function as a well-connected node in very large European networks rather than a tight-knit group of repeat collaborators.

An exceptionally broad network of 254 partners across 32 countries, driven largely by participation in the massive Human Brain Project consortium. Their geographic footprint spans nearly all EU member states and associated countries.

What sets them apart

UMG sits at a rare intersection: they combine clinical medicine and population epidemiology with deep computational neuroscience and HPC expertise from years inside the Human Brain Project. For consortium builders, this means a single partner that can bridge health data, brain research, and data infrastructure — a combination few university medical centers can offer. Their coordination of citizen-science and cohort-based projects also shows capacity to lead public engagement components in health-focused proposals.

Highlights from their portfolio

• HBP SGA3
  Final phase of the EUR 1B+ Human Brain Project — UMG's longest commitment (2016-2023 across all three SGAs), contributing to the EBRAINS research infrastructure.
• EUthyroid
  UMG's largest funded project (EUR 572,602) and a coordinator role addressing iodine deficiency prevention across Europe — directly tied to their clinical mandate.
• JoinUs4Health
  Most recent coordinated project (2021-2023), pioneering citizen science and crowdsourcing approaches to cohort research — signals a strategic shift toward public engagement.